.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Julphar
Dow
Johnson and Johnson
Farmers Insurance
Harvard Business School
Cipla
Healthtrust
Covington
Fish and Richardson

Generated: December 17, 2017

DrugPatentWatch Database Preview

Claims for Patent: 4,501,893

« Back to Dashboard

Claims for Patent: 4,501,893

Title: 3-{6-[3-Pyrrolidino-1-(4-tolyl)prop-1-enyl]-2-pyridyl}acrylic acid and pharmaceutically acceptable salts thereof
Abstract:This disclosure describes a compound of Formula I ##STR1## (including its pharmaceutically acceptable salts and esters) which has potent antihistamine activity which is substantially free from sedative effects and which has little or no anticholinergic effects.
Inventor(s): Findlay; John W. A. (Chapel Hill, NC), Coker; Geoffrey G. (Bromley, Kent, GB2)
Assignee:
Application Number:06/462,872
Patent Claims: 1. The compound of formula (I) ##STR10## straight and branched lower alkyl (1-4 carbon atoms) esters, and pharmaceutically acceptable salts thereof.

2. The compound of claim 1 as the hydrochloride salt.

3. The compound of claim 1 as the sulfate salt.

4. The compound of claim 1 as the hydrobromide salt.

5. The compound of claim 1 as the tartrate salt.

6. The compound of claim 1 as the citrate salt.

7. The compound of claim 1 as the succinate salt.

8. The compound of claim 1 as the sodium salt.

9. The compound of claim 1 as the potassium salt.

10. The compound of claim 1 as the calcium salt.

11. The compound of claim 1 which is the methyl ester.

12. The compound of claim 1 which is the ethyl ester.

13. The compound of claim 1 which is the propyl ester.

14. The compound of claim 1 which is the butyl ester.

15. (E)-3-{6-[3-Pyrrolidino-1-(4-tolyl)prop-1E-enyl]-2-pyridyl}acrylic acid.

16. The compound of formula (I) ##STR11## or a pharmaceutically acceptable salt thereof.

17. A pharmaceutically acceptable salt of (E)-3-{6-[3-Pyrrolidino-1-(4-tolyl)prop-1E-enyl]-2-pyridyl}acrylic acid.

18. The hydrochloride salt of claim 17.

19. The salt of claim 17 which is an acid addition salt.

20. The salt of claim 17 which is an alkaline metal or alkaline earth salt.

21. The tartrate salt of claim 17.
« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Covington
Fish and Richardson
US Department of Justice
Farmers Insurance
Daiichi Sankyo
Express Scripts
Teva
Boehringer Ingelheim
AstraZeneca
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot